OQS
CNCE

Occudo Quantitative Strategies’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Occudo Quantitative Strategies’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,418
Closed -$143K – 1293
2022
Q4 		$143K Sell
24,418
-38,386
-61% -$202K 0.02% 820
2022
Q3 		$421K Buy
+62,804
New +$381K 0.03% 723

Occudo Quantitative Strategies's CNCE Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 24,418 shares — an estimated $143K sold.

Occudo Quantitative Strategies first reported a position in CNCE in Q3 2022 and held it in 2 quarters. The position peaked at $421K in Q3 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

  • Occudo Quantitative Strategies reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 24,418 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $143K.
  • Occudo Quantitative Strategies first reported a position in Concert Pharmaceuticals, Inc. in Q3 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Concert Pharmaceuticals, Inc. position peaked at $421K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.